These findings highlight the notion that inflammation occurs in the early stages of obesity and glucose dysregulation, and inflammation may be a key mechanism responsible for changes in epidermal innervation that subsequently leads to the development of PN in insulin resistant humans. This evidence concerns the gene INS and obesity disorder.